USC/Kenneth Norris Comprehensive Cancer Center USC 2 — Los Angeles, California

USC/Kenneth Norris Comprehensive Cancer Center USC 2 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USC/Kenneth Norris Comprehensive Cancer Center USC 2 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USC/Kenneth Norris Comprehensive Cancer Center USC 2?

USC/Kenneth Norris Comprehensive Cancer Center USC 2 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USC/Kenneth Norris Comprehensive Cancer Center USC 2 conducted?

USC/Kenneth Norris Comprehensive Cancer Center USC 2 has 1 clinical trials on record. Their work covers Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment.

Is USC/Kenneth Norris Comprehensive Cancer Center USC 2 accredited by Crixeo Clinical Trials?

USC/Kenneth Norris Comprehensive Cancer Center USC 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USC/Kenneth Norris Comprehensive Cancer Center USC 2?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.